Search results
Results from the WOW.Com Content Network
In Kenya, drug use is an ongoing prevalent issue among those from both rural and urban areas of the country. Drugs such as inhalants, narcotics, and prescription drugs have been abused, resulting in societal issues such as social stigmas, poverty, peer pressure. These issues have had significant repercussions, including increased violence ...
Download as PDF; Printable version; In other projects Wikidata item; ... Pages in category "Drugs in Kenya" The following 4 pages are in this category, out of 4 total.
East African drug trade refers to the sale and trafficking of illegal drugs that take place in East African countries like Kenya, Tanzania, Uganda, Somalia, and Ethiopia. . The most prevalent types of drugs traded in East Africa are heroin, marijuana, cocaine, methamphetamine, and khat, all of which are strictly prohibited in East African countri
In the Corruption Perceptions Index 2007, Kenya was ranked 150th out of 179 countries for corruption (least corrupt countries are at the top of the list). [6] In 2007, on a scale of 0 to 10, with 0 the most corrupt and 10 the most transparent, Transparency International rated Kenya 2.1.
Kemron is the name of a drug which was released in Kenya in 1991 and was alleged to be highly effective in removing the symptoms of AIDS. When put under international scrutiny, the treatment was seen to perform no better than placebo. The advent of the drug was notable for the government support and international attention it received.
The Pharmacy and Poisons Act, Cap 244 is an Act of Parliament to make better provision for the Control of the Profession of Pharmacy and trade in drugs and poisons. The Pharmacy and Poisons Board is established as a body corporate, under the Pharmacy and Poisons Act, Cap 244 Laws of Kenya. The PPB is regulatory body within the Ministry of ...
This is a list of countries (and some territories) by the annual prevalence of opiates use as percentage of the population aged 15–64 (unless otherwise indicated).. The primary source of information are the World Drug Report 2011 (WDR 2011) and the World Drug Report 2006 (WDR 2006), [1] [2] published by the United Nations Office on Drugs and Crime (UNODC).
The cost per year for this drug treatment is US$75 and is a big improvement as it combines some drugs together to make the treatment plan cheaper and easier for patients living with HIV. This drug has been accessible in high income countries since 2014, but the new deal has placed the drug in middle and low income countries. [12]